Mahanagar Gas rolls out PNG benefits, waives charges to boost adoption

Mahanagar Gas rolls out incentives for PNG users, including bill benefits and fee waivers, while assuring uninterrupted supply of PNG and CNG; shares rise nearly 2% in trade.

Mahanagar Gas rolls out incentives for PNG users, including bill benefits and fee waivers, while assuring uninterrupted supply of PNG and CNG; shares rise nearly 2% in trade.
Abneesh Roy, ED of Nuvama Institutional Equities, says recent price increases could support paint companies’ margins and drive better revenue growth than volumes in FY27, aided by operating leverage and more disciplined industry pricing. He expects further action if input…

For FY27, JPMorgan expects Infosys to report revenue growth of 2% to 5%, while HCL Technologies is seen growing at 3% to 6%. Wipro, however, is expected to report sequential growth of -2% to 0%.

Urban Company had listed on the stock exchanges at a 60% premium in September 2025 and is now down 43.8% from its post-listing high of ₹201.18 apiece.

Mark Matthews of Bank Julius Baer & Co says India’s stock market could see a recovery despite global volatility and foreign outflows. Valuations have cooled, making the market more attractive, while mid and small caps show resilience due to strong…
Mayuresh Joshi, Director Research at Marketsmith India, says easing crude offers near-term relief, especially for aviation, where lower ATF can aid margins. He prefers a gradual, sector-specific approach amid volatility, with pharma and energy showing resilience. While valuations are turning…

.Nomura has upgraded its rating on Kotak Mahindra Bank to ‘buy’ with a target price of ₹445 per share, an upside potential of 24.8%.

ASK Private Wealth Chief Investment Officer Somnath Mukherjee advises long-term investors to stay disciplined and avoid trying to time market bottoms amid ongoing global uncertainties. He highlights that inflation and elevated interest rates are likely to persist, making asset allocation…

Citi has reiterated its’buy’ rating on Apollo Hospitals with a price target of ₹9,600 per share and has added the stock to its pan-Asia focus list as ‘buy’. This is an upside of 34% from its previous close.

NCLAT lets Adani Enterprises resolution plan for Jaiprakash Associates proceed, as Vedanta challenges CoC for rejecting its higher NPV bid under IBC principles.